2 May 2017

Heart attack biomarker unravelled for the first time

According to Sander Streng, a researcher at Maastricht University, the hospital test used to determine whether someone has had a heart attack needs improving. His research focuses primarily on the protein troponin T and the hospital test aims to determine the concentration of this substance in the bloodstream. Using mass spectrometry and other technologies, Streng was the first to identify the individual molecular components of troponin T. Refining the diagnostic test can help rule out false positive results, which sometimes occur among kidney patients, diabetics, elderly people and athletes. Streng will receive his PhD from Maastricht University on Thursday 4 May.